|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Patento numeris | 2894231 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15151581.4 |
| Europos patento paraiškos padavimo data | 2010-08-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 09167184 | 2009-08-04 | EP |
| (72) |
Foernzler, Dorothee, CH
Delmar, Paul, CH
Scherer, Stefan, CH
Lambrechts, Diether, BE
Carmeliet, Peter, BE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
VIB vzw, Rijvisschestraat 120, 9052 Gent, BE Life Sciences Research Partners VZW, Campus Gasthuisberg Herestraat 49, bus 913, 3000 Leuven, BE |
| (54) | Responsiveness to angiogenesis inhibitors |
| Responsiveness to angiogenesis inhibitors |